Skip to main content
Top
Published in: Cancer and Metastasis Reviews 1/2023

21-01-2023 | Metastasis | EDITORIAL

Dormancy in cancer metastasis: keys to moving forward

Author: Danny R. Welch

Published in: Cancer and Metastasis Reviews | Issue 1/2023

Login to get access

Excerpt

If diagnosed prior to spread, surgical removal of cancer is curative. If metastases already exist at the time of diagnosis, prognosis drops dramatically, and quality-of-life is significantly diminished [1]. It is cancers in patients with no evidence of metastases — but in whom the cancer cells have already disseminated and will recur later — that are the focus of this special issue of Cancer and Metastasis Reviews. Recurrence of cancer is always devastating news. But when the cancer has lain dormant for months or years before resurrection, the psychological impact on cancer patients is doubly difficult. Likewise, during this silent phase of cancer, accumulations of additional mutations likely contribute to subsequent difficulties in controlling the disease [2]. …
Literature
Metadata
Title
Dormancy in cancer metastasis: keys to moving forward
Author
Danny R. Welch
Publication date
21-01-2023
Publisher
Springer US
Keyword
Metastasis
Published in
Cancer and Metastasis Reviews / Issue 1/2023
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-023-10083-5

Other articles of this Issue 1/2023

Cancer and Metastasis Reviews 1/2023 Go to the issue
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare